EPO and myocardial ischemia: In contrast, intravenous treatment with erythropoietin (2500 U/kg × 2) 24 h and 30 min prior to the induction of myocardial ischemia, which promotes cardioprotection from IR injury through cyclophilin D-independent mechanisms20, reduced IR injury in the cyclophilin D−/− mice.